The iconic rise of copyright’s flagship product presented a massive chance for investors , but its patent has lapsed , creating a complex landscape. Off-brand versions have appeared in the space , cutting into revenues and putting a strain on profit percentages . While major pharmaceutical companies hold a stake in this field , the future looks … Read More